Haw Par (FRA:H4V) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H4V Haw Par Corp Ltd FRA:H4V
73 GF Score
Price €11.86
GF Value €8.81
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Haw Par FFO per Share?

FFO per Share only applies to REITs.

FRA:H4V
73GF Score
Haw Par Corp Ltd FRA:H4V
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Haw Par (FRA:H4V) Overvalued in 2026?

Based on GuruFocus' analysis, Haw Par stock appears to be overvalued. The current stock price of €11.86 is trading 34.6% above its estimated GF Value™ of €8.81. GuruFocus considers Haw Par to be Significantly Overvalued.

Key valuation signals for FRA:H4V:

  • FFO per Share:
  • GF Value™: €8.81 vs. price of €11.86 (34.6% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the FRA:H4V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haw Par Business Description

Other Exchanges H02:Singapore
Address 401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
73GF Score

Get the complete analysis for FRA:H4V

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.86
Price
€8.81
GF Value